139 related articles for article (PubMed ID: 37156117)
1. Xanthotoxin, a novel inducer of platelet formation, promotes thrombocytopoiesis via IL-1R1 and MEK/ERK signaling.
Lai J; Li Y; Ran M; Huang Q; Huang F; Zhu L; Wu Y; Zou W; Xie X; Tang Y; Yang F; Wu A; Ge G; Wu J
Biomed Pharmacother; 2023 Jul; 163():114811. PubMed ID: 37156117
[TBL] [Abstract][Full Text] [Related]
2. Alnustone promotes megakaryocyte differentiation and platelet production via the interleukin-17A/interleukin-17A receptor/Src/RAC1/MEK/ERK signaling pathway.
Li Y; Lai J; Ran M; Yi T; Zhou L; Luo J; Liu X; Tang X; Huang M; Xie X; Li H; Yang Y; Zou W; Wu J
Eur J Pharmacol; 2024 May; 971():176548. PubMed ID: 38570080
[TBL] [Abstract][Full Text] [Related]
3. Hirsutine, a novel megakaryopoiesis inducer, promotes thrombopoiesis via MEK/ERK/FOG1/TAL1 signaling.
Kang Y; Lin J; Wang L; Shen X; Li J; Wu A; Yue L; Wei L; Ye Y; Yang J; Wu J
Phytomedicine; 2022 Jul; 102():154150. PubMed ID: 35569185
[TBL] [Abstract][Full Text] [Related]
4. Novel chemical-structure TPOR agonist, TMEA, promotes megakaryocytes differentiation and thrombopoiesis via mTOR and ERK signalings.
Jiang X; Sun Y; Yang S; Wu Y; Wang L; Zou W; Jiang N; Chen J; Han Y; Huang C; Wu A; Zhang C; Wu J
Phytomedicine; 2023 Feb; 110():154637. PubMed ID: 36610353
[TBL] [Abstract][Full Text] [Related]
5. A Novel Antithrombocytopenia Agent,
Chen W; Zhu L; Wang L; Zeng J; Wen M; Xu X; Zou L; Huang F; Huang Q; Qin D; Mei Q; Yang J; Wang Q; Wu J
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430539
[TBL] [Abstract][Full Text] [Related]
6. Activating SRC/MAPK signaling via 5-HT1A receptor contributes to the effect of vilazodone on improving thrombocytopenia.
Zhou L; Ni C; Liao R; Tang X; Yi T; Ran M; Huang M; Liao R; Zhou X; Qin D; Wang L; Huang F; Xie X; Wan Y; Luo J; Wang Y; Wu J
Elife; 2024 Apr; 13():. PubMed ID: 38573820
[TBL] [Abstract][Full Text] [Related]
7. The role of CREG1 in megakaryocyte maturation and thrombocytopoiesis.
Song H; Li J; Peng C; Liu D; Mei Z; Yang Z; Tian X; Zhang X; Jing Q; Yan C; Han Y
Int J Biol Sci; 2023; 19(11):3614-3627. PubMed ID: 37496998
[TBL] [Abstract][Full Text] [Related]
8. Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
Wang L; Liu S; Luo J; Mo Q; Ran M; Zhang T; Li X; Zou W; Mei Q; Chen J; Yang J; Zeng J; Huang F; Wu A; Zhang C; Wu J
Haematologica; 2023 May; 108(5):1394-1411. PubMed ID: 36546424
[TBL] [Abstract][Full Text] [Related]
9. The role of AGK in thrombocytopoiesis and possible therapeutic strategies.
Jiang H; Yu Z; Ding N; Yang M; Zhang L; Fan X; Zhou Y; Zou Q; Hou J; Zheng J; Zhang L; Xu Y; Liu J
Blood; 2020 Jul; 136(1):119-129. PubMed ID: 32202634
[TBL] [Abstract][Full Text] [Related]
10. DMAG, a novel countermeasure for the treatment of thrombocytopenia.
Lin J; Zeng J; Liu S; Shen X; Jiang N; Wu YS; Li H; Wang L; Wu JM
Mol Med; 2021 Nov; 27(1):149. PubMed ID: 34837956
[TBL] [Abstract][Full Text] [Related]
11. Branched-chain amino acids promote thrombocytopoiesis by activating mTOR signaling.
Jiang H; Zhang L; Yang M; Li G; Ding C; Xin M; Dai J; Sun X; Fan X; Sun H; Liu J; Xu Y
J Thromb Haemost; 2023 Nov; 21(11):3224-3235. PubMed ID: 37473846
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA NORAD regulates megakaryocyte differentiation and proplatelet formation via the DUSP6/ERK signaling pathway.
Wang Y; Lv Y; Jiang X; Yu X; Wang D; Liu D; Liu X; Sun Y
Biochem Biophys Res Commun; 2024 Jun; 715():150004. PubMed ID: 38678784
[TBL] [Abstract][Full Text] [Related]
13. Discovery of a novel megakaryopoiesis enhancer, ingenol, promoting thrombopoiesis through PI3K-Akt signaling independent of thrombopoietin.
Wang L; Zhang T; Liu S; Mo Q; Jiang N; Chen Q; Yang J; Han YW; Chen JP; Huang FH; Li H; Zhou J; Luo JS; Wu JM
Pharmacol Res; 2022 Mar; 177():106096. PubMed ID: 35077844
[TBL] [Abstract][Full Text] [Related]
14. Targeting TLR2/Rac1/cdc42/JNK Pathway to Reveal That Ruxolitinib Promotes Thrombocytopoiesis.
Yang S; Tang X; Wang L; Ni C; Wu Y; Zhou L; Zeng Y; Zhao C; Wu A; Wang Q; Xu X; Wang Y; Chen R; Zhang X; Zou L; Huang X; Wu J
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555781
[TBL] [Abstract][Full Text] [Related]
15. Thrombopoietic stimulating activity of rhTyrRS (Y341A).
Jinchao Y; Yanling Z; Xu W; Bing Z; Yuhao Y; Weiran Z; Shaoyang S; Liyun M; Yun S; Ling Z; Min Y; Wei M
Sci Rep; 2017 Sep; 7(1):12184. PubMed ID: 28939876
[TBL] [Abstract][Full Text] [Related]
16. Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway.
Ye JY; Chan GC; Qiao L; Lian Q; Meng FY; Luo XQ; Khachigian LM; Ma M; Deng R; Chen JL; Chong BH; Yang M
Haematologica; 2010 Oct; 95(10):1745-53. PubMed ID: 20562316
[TBL] [Abstract][Full Text] [Related]
17.
Yang X; Wang L; Zeng J; Wu A; Qin M; Wen M; Zhang T; Chen W; Mei Q; Qin D; Yang J; Jiang Y; Wu J
Pharmaceuticals (Basel); 2022 Sep; 15(10):. PubMed ID: 36297316
[TBL] [Abstract][Full Text] [Related]
18. Megakaryocyte modification of platelets in thrombocytopenia.
Roweth HG; Parvin S; Machlus KR
Curr Opin Hematol; 2018 Sep; 25(5):410-415. PubMed ID: 29985173
[TBL] [Abstract][Full Text] [Related]
19. Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis.
Dou C; Chen Y; Ding N; Li N; Jiang H; Zhao C; Kang F; Cao Z; Quan H; Luo F; Xu J; Dong S
Osteoporos Int; 2016 Jul; 27(7):2335-2344. PubMed ID: 26809192
[TBL] [Abstract][Full Text] [Related]
20. Thrombopoietic effects of CCAAT/enhancer-binding protein β on the early-stage differentiation of megakaryocytes.
Song H; Liu J; Tian X; Liu D; Li J; Zhao X; Mei Z; Yan C; Han Y
Arch Biochem Biophys; 2021 May; 703():108846. PubMed ID: 33744198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
